Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human CFTR Stable Cell Line

    [CAT#: S01YF-1123-KX83]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Ion Channel Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    CFTR
    Target Family
    Cystic Fibrosis Transmembrane Conductance Regulator
    Target Protein Species
    Human
    Host Cell Type
    A2780; SKOV3; CHO-K1; HEK293
    Target Classification
    Ion Channel Cell Lines
    Target Research Area
    Reproductive Research
    Related Diseases
    Cystic Fibrosis; Vas Deferens, Congenital Bilateral Aplasia Of
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    Instructions for producing the CF transmembrane conductance regulator (CFTR) protein are found in the CFTR gene. This protein serves as a conduit across the membrane of the cells that secrete digestive enzymes, perspiration, saliva, and mucus. Chloride ions, which are negatively charged particles, are transported into and out of cells via the channel. Chloride ion transport aids in regulating tissue water flow, which is essential for the synthesis of thin, fluid mucus. Other channels, such those that move positively charged particles called sodium ions across cell membranes, are also controlled by the CFTR protein. Organs like the pancreas and lungs cannot function normally without these channels. The customized CFTR stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat William

    I am truly impressed with the performance of this CFTR cell line and the professionalism of Creative Biolabs. I highly recommend it to anyone. May 06 2020

    chat Verified Customer

    chat John

    I purchased the CFTR cell line from Creative Biolabs. The provided documentation was comprehensive and helped me optimize my assay conditions. Nov 15 2020

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 The CFTR-specific shRNA expression pGFP-V-RS vectors were used to transfect the human A2780 and SKOV3 epithelial ovarian cancer cell lines, and the stably transfected cells were then chosen.

    Western blot analysis was used to quantify the CFTR protein (~170 kDa) in each puromycin-resistant cell, GFP-positive cell colonies, and negative control cells. As an internal control, β-actin (~43 kDa) was employed.

    Ref: Xu, Jiao, et al. "High level of CFTR expression is associated with tumor aggression and knockdown of CFTR suppresses proliferation of ovarian cancer in vitro and in vivo." Oncology Reports 33.5 (2015): 2227-2234.

    Pubmed: 25738998

    DOI: 10.3892/or.2015.3829

    Research Highlights

    Although it is a member of the ATP binding cassette (ABC) transporter superfamily, the cystic fibrosis transmembrane conductance regulator (CFTR) serves as an anion channel that is essential for the passage of salt and water through epithelial cells.
    Csanády, László, Paola Vergani, and David C. Gadsby. "Structure, gating, and regulation of the CFTR anion channel." Physiological reviews 99.1 (2019): 707-738.
    Pubmed: 30516439   DOI: 10.1152/physrev.00007.2018

    Modulator for CFTR theratyping is a new and quickly developing discipline that may be able to find uncommon CFTR variations that respond to medicines that are either approved or under development.
    Clancy, John Paul, et al. "CFTR modulator theratyping: Current status, gaps and future directions." Journal of Cystic Fibrosis 18.1 (2019): 22-34.
    Pubmed: 29934203   DOI: 10.1016/j.jcf.2018.05.004

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare